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314, 318, and 325. In the United States 700,000 strokes occur each year, and these are the thirdleading cause of death.1 Of the 167,661 deaths from stroke reported by theAmerican Heart Association in 2000, 102,892 were among women and64,769 were among men.1 Women (53%) in the United States are reportedto experience strokes more frequently than men but at a more advancedage.1 When examining sex differences, the prevalence of stroke must be
controlled for age because women have a longer life expectancy, and the occurrence
of stroke increases dramatically with increasing age. In the year 2000 the age-
adjusted first-event stroke rates (per 100,000) were as follows: 167 for white men,
138 for white women, 323 for African American men, and 260 for African
American women. Age-standardized mortalities for ischemic stroke were higher for
women age 65 years and older from 1995 through 1998.1 Most (61%) strokes are
reported to be caused by atherothrombotic events.1 Atherosclerosis and stenosis of
the carotid arteries are known clinical entities associated with stroke. The overall
prevalence of carotid stenosis in patients who experience ischemic strokes, however,
remains unknown.
Most aspects regarding carotid endarterectomy (CEA) for stroke prevention have
been examined. Patient eligibility, surgical indications, technical considerations, and
detailed outcome expectations have been defined. Unfortunately, most of this
scientific effort has assumed that men and women have no significant difference in
outcome after CEA or the natural history of carotid stenosis. Challenges to this
assumption have been raised. The Asymptomatic Carotid Atherosclerosis Study,2 in
1995, sparked a debate that continues. The purpose of the study was to compare
medical and surgical treatment of patients with asymptomatic internal carotid artery
stenosis greater than or equal to 60%. Subjects were randomly assigned to medical
or surgical treatment and separated by the degree of stenosis identified. They were
followed for 2.7 years for cerebrovascular events, which included stroke, transient
ischemic attack, and death. Approximately one third of the total patients enrolled
were women (568/1659); however, conclusions were made that questioned the
protection CEA offers asymptomatic women. The 5-year stroke risk–reduction rate
was 66% for men and only 17% for women. The authors suggested that this muted
benefit for women occurred because they had a higher incidence of perioperative
events (3.6%).
Three years later, post hoc analysis of patients with symptomatic carotid stenosis
analyzed in the North American Symptomatic Carotid Endarterectomy Trial also
suggested that women experienced less benefit from CEA.3 This prospective study
demonstrated that women with 50% to 69% symptomatic stenosis had a lower
stroke risk when managed medically. Interestingly, this study did not demonstrate
higher perioperative stroke and death rates in women when compared with men.
This study also enrolled relatively few women (63) compared with men (137).
The conclusion that women derive less benefit from CEA is viewed with some
skepticism. Despite the excellent design of the North American Symptomatic
Carotid Endarterectomy Trial and Asymptomatic Carotid Atherosclerosis Study in
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terms of prospective enrollment and random assignment to
treatment groups, these studies were not designed with the
purpose of exploring differences in outcome on the basis of
sex. This fact is demonstrated in the most glaring flaw of
both studies, the relatively low number of women enrolled.
Proper examination of the outcomes of CEA would require
a large sample size because of the low rate of events.
A number of surgeons published their institution’s re-
sults regarding women who underwent CEA (Table 1).1,4-9
Patients were generally a mixed population, with symptom-
atic and asymptomatic disease. For example, Mattos and
colleagues,4 from the Southern Illinois University School of
Medicine, examined long-term outcome after CEA. They
analyzed data from 454 women and 739 men who under-
went CEA for asymptomatic and symptomatic stenoses.
Follow-up data were available for 70% of patients up to 8
years after surgical intervention. No significant differences
were reported to have occurred in perioperative stroke and
mortality for men and women when divided into symptom-
atic and asymptomatic groups. The data showed long-term,
stroke-free survival was the same for men and women after
CEA. Also, long-term survival after CEA was improved for
women in both the symptomatic and asymptomatic groups
when compared with men.4
Sarac and associates5 published a series from the Cleve-
land Clinic Foundation of 3077 patients (1148 women) in
2002. Data were available for the perioperative period only,
and therefore no long-term benefit of CEA could be deter-
mined; however, women without symptoms before CEA
had a significantly higher stroke rate than men. Transient
ischemic attack rates and mortalities for the asymptomatic
group were not significantly different between women and
men. However, they concluded that even with the higher
stroke rate in asymptomatic women, CEA should be per-
formed because complication rates were acceptable (2.2%
stroke rate). No difference was reported between symptom-
atic men and women for perioperative transient ischemic
attack rates, stroke rates, and mortalities.
Rockman and coworkers6 from New York Medical Cen-
ter reported their series of CEAs (991 women and 1485
men) for symptomatic and asymptomatic patients. No dif-
ferences in perioperative stroke rates between men and
women were present, even when divided by preoperative
symptoms. In fact, the subgroup with the lowest stroke rate
was asymptomatic women, although this difference did not
reach statistical significance. Only in-hospital data were
available, and therefore no determination of long-term ben-
efit of CEA could be made. Akbari and colleagues,7 Stern-
bach and Perler,8 James and associates,9 and Schneider and
coworkers10 also published similar reports that demon-
strated no statistical difference in perioperative stroke and
mortality for women at their institution.
TABLE 1. Perioperative and late outcomes of carotid endarterectomy comparing men and women
Reference Asymptomatic women Asymptomatic men Symptomatic women Symptomatic men
Mattos and colleagues4 n  154 (33%) n  247 (33%) n  311 (67%) n  492 (67%)
Death  0 (0%) Death  2 (0.8%) Death  1 (0.3%) Death  4 (0.8%)
CVA  1 (0.6%) CVA  3 (1.2%) CVA  9 (2.9%) CVA  22 (4.5%)
5-y death  9 (18%) 5-y death  38 (38%) 5-y death  40 (28%) 5-y death  94 (38%)
5-y CVA  (0%) 5-y CVA  (10%) 5-y CVA  (18%) 5-y CVA  (15%)
Sarac and colleagues5 n  787 (69%) n  1586 (70%) n  361 (31%) n  688 (30%)
Death  7 (0.9%) Death  12 (0.8%) Death  7 (1.9%) Death  8 (1.2%)
CVA  17 (2.2%)* CVA  16 (1%)* CVA  12 (3.3%) CVA  20 (2.9%)
Rockman and colleagues6 n  332 (33%) n  444 (30%) n  659 (67%) n  1041 (70%)
CVA  4 (1.2%) CVA  9 (2.0%) CVA  20 (3.0%) CVA  25 (2.5%)
Death  5 (0.5%)† Death  16 (1.1%)†
Akbari and colleagues7 n  263 (51%) n  343 (44%) n  257 (49%) n  453 (56%)
CVA  3 (0.6%) CVA  3 (0.4%) CVA  6 (2.3%) CVA  7 (1.6%)
Death  1 (0.2%)† Death  3 (0.4%)†
Sternbach and Perler8 n  66 (44%) n  83 (56%) NA NA
Death  0 (0%) Death  0 (0%)
CVA  0 (0%) CVA  1 (1.3%)
James and colleagues9 n  64 (51%) n  89 (45%) n  61 (49%) n  110 (55%)
Death  1 (0.8%)† Death  0 (0%)†
CVA  3 (2.4%)† CVA  3 (1.5%)†
Schneider and colleagues1 n  46 (30%) n  63 (23%) n  109 (70%) n  208 (67%)
Death  1 (0.7%)† Death  0 (0%)†
CVA  5 (3.2%)† CVA  4 (1.5%)†
CVA, Cerebrovascular accident or stroke. Death refers to 30-day mortality. Five-year death refers to death from any cause during long-term follow-up.
Five-year CVA refers to ipsilateral stroke during long-term follow-up.
*P  .05, asymptomatic women compared with asymptomatic men.
†Combined symptomatic and asymptomatic patients.
Harthun et al Editorials
The Journal of Thoracic and Cardiovascular Surgery ● Volume 127, Number 2 323
ED
IT
O
RI
A
L
Differences have been reported between men and women
in the rate of early (5 years) restenosis after CEA. Most of
the studies performed on the subject of restenosis examined
the type of closure (patch or primary) or patch material used
(polytetrafluoroethylene, vein, or Dacron). Most of these
reports demonstrated that women had a significantly higher
restenosis rate than men. Four studies associated the higher
rate of early restenosis in women only with primary clo-
sure,11-14 and 2 other studies reported this difference for
vein15,16 and Dacron16 patch closures as well. The primary
objective of these studies was not to examine differences
between men and women, which limits the ability to explain
why this difference exists. One report measured the internal
carotid artery diameter and reported no significant differ-
ence in diameter between men and women undergoing
CEA.12 In the same study no significant diameter difference
was found when comparing arteries in which restenosis
developed after CEA and arteries that remained widely
patent. It should be noted that this issue remains controver-
sial. Despite the large number of reports that support a
sex-based difference in development of early carotid reste-
nosis, several studies did not demonstrate such a differ-
ence.17-19
As evidenced by this review, it remains unclear whether
women derive the same benefit as men from CEA. This
issue needs to be resolved for 3 main reasons.
1. It restricts progress toward defining a pathophysio-
logic basis for any sex-based differences. For exam-
ple, it has been suggested that women’s arteries are
smaller, which might predispose women to thrombosis
after CEA,2 although this has not been a consistent
finding.12 Additionally, some data suggest that use of
hormone replacement therapy might predispose
women to perioperative stroke.20
2. Further examination of the true benefits of CEA in
women needs to be addressed because the debate itself
might have an effect on patient selection for this
procedure. Consistent with this concern, several re-
ports suggest CEA is not performed for women who
would meet the conventional criteria for surgical in-
tervention.21,22
3. As new therapies for carotid stenosis are developed,
they should be examined properly for men and
women. For example, percutaneous stenting of carotid
artery stenosis as primary treatment for asymptomatic
patients is being evaluated currently in clinical trials.
If sex-based differences for standard carotid therapy
were better understood, these clinical trials could potentially
be improved to also examine these factors.
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